exclusive, exclusive, or partially exclusive: Invaplex vaccine,

Text

---

Federal Register: August 5, 2002 (Volume 67, Number 150)NoticesPage 50652From the Federal Register Online via GPO Access [wais.access.gpo.gov]

DOCID:fr05au02-39

DEPARTMENT OF DEFENSE

Department of the Army

Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Patent Application Concerning Heterologous Protection Induced by Immunization With Invaplex Vaccine

AGENCY: Department of the Army, DoD.

ACTION: Notice.

SUMMARY: In accordance with 37 CFR 404.6 and 404.7, announcement is made of the availability for licensing of U.S. Patent Application No. 10/150,814 entitled ``Heterologous Protection Induced by Immunization with Invaplex Vaccine,'' filedMay 17, 2002. Foreign rights (PCT/US02/ 16029) are also available. The United States Government, as represented by the Secretary of the Army has rights in this invention.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, Frederick, Maryland 21702-5012.

FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul Mele, Office of Research & Technology Assessment, (301) 619-6664, both at telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: In this application is described a composition, Invaplex, derived from a gram negative bacteria for use in generating an immune response in a subject against one or more heterologous species or strains of gram-negative bacteria.

Luz D. Ortiz, Army Federal Register Liaison Officer.

FR Doc. 02-19710Filed8-2-02; 8:45 amBILLING CODE 3710-08-M

---